2020 Q2 Form 10-Q Financial Statement

#000166013420000012 Filed on May 29, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $182.9M $125.2M
YoY Change 46.03% 49.75%
Cost Of Revenue $48.49M $35.10M
YoY Change 38.16% 45.58%
Gross Profit $134.4M $90.13M
YoY Change 49.09% 51.44%
Gross Profit Margin 73.48% 71.97%
Selling, General & Admin $138.1M $107.9M
YoY Change 27.99% 67.09%
% of Gross Profit 102.76% 119.69%
Research & Development $48.49M $34.03M
YoY Change 42.5% 70.77%
% of Gross Profit 36.09% 37.76%
Depreciation & Amortization $5.500M $3.400M
YoY Change 61.76% 61.9%
% of Gross Profit 4.09% 3.77%
Operating Expenses $186.6M $141.9M
YoY Change 31.47% 67.96%
Operating Profit -$52.20M -$51.78M
YoY Change 0.81% 107.31%
Interest Expense $10.76M $4.241M
YoY Change 153.81% 56.09%
% of Operating Profit
Other Income/Expense, Net $4.899M $2.900M
YoY Change 68.93% 93.08%
Pretax Income -$58.10M -$53.10M
YoY Change 9.42% 102.67%
Income Tax -$400.0K -$1.200M
% Of Pretax Income
Net Earnings -$57.66M -$51.97M
YoY Change 10.96% 100.16%
Net Earnings / Revenue -31.53% -41.5%
Basic Earnings Per Share -$0.47
Diluted Earnings Per Share -$0.47 -$461.4K
COMMON SHARES
Basic Shares Outstanding 123.5M shares
Diluted Shares Outstanding 123.5M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.447B $547.5M
YoY Change 164.26% 0.09%
Cash & Equivalents $619.2M $208.1M
Short-Term Investments $827.6M $339.4M
Other Short-Term Assets $75.70M $46.10M
YoY Change 64.21% 18.81%
Inventory
Prepaid Expenses
Receivables $111.0M $83.33M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.634B $676.9M
YoY Change 141.31% 6.41%
LONG-TERM ASSETS
Property, Plant & Equipment $61.91M $52.19M
YoY Change 18.63% 172.16%
Goodwill $48.00M $48.00M
YoY Change 0.0% 664.09%
Intangibles $31.03M $28.02M
YoY Change 10.74% 136.21%
Long-Term Investments
YoY Change
Other Assets $20.48M $16.70M
YoY Change 22.66% 35.28%
Total Long-Term Assets $403.5M $321.6M
YoY Change 25.46% 254.43%
TOTAL ASSETS
Total Short-Term Assets $1.634B $676.9M
Total Long-Term Assets $403.5M $321.6M
Total Assets $2.037B $998.5M
YoY Change 104.0% 37.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.021M $4.352M
YoY Change 84.31% -63.21%
Accrued Expenses $68.00M $53.90M
YoY Change 26.16% 208.0%
Deferred Revenue $392.1M $268.0M
YoY Change 46.3% 54.44%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $102.2M $275.7M
YoY Change -62.93%
Total Short-Term Liabilities $570.4M $601.9M
YoY Change -5.24% 196.62%
LONG-TERM LIABILITIES
Long-Term Debt $845.9M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $6.702M $3.470M
YoY Change 93.14% -65.63%
Total Long-Term Liabilities $6.702M $3.470M
YoY Change 93.14% -65.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $570.4M $601.9M
Total Long-Term Liabilities $6.702M $3.470M
Total Liabilities $1.624B $759.1M
YoY Change 113.93% 59.04%
SHAREHOLDERS EQUITY
Retained Earnings -$758.8M -$544.2M
YoY Change 39.44% 38.58%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $413.1M $239.4M
YoY Change
Total Liabilities & Shareholders Equity $2.037B $998.5M
YoY Change 104.0% 37.37%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$57.66M -$51.97M
YoY Change 10.96% 100.16%
Depreciation, Depletion And Amortization $5.500M $3.400M
YoY Change 61.76% 61.9%
Cash From Operating Activities $38.70M $21.26M
YoY Change 82.0% 435.3%
INVESTING ACTIVITIES
Capital Expenditures $7.930M $7.710M
YoY Change 2.85% 72.21%
Acquisitions $0.00 $44.22M
YoY Change -100.0%
Other Investing Activities $59.50M -$117.5M
YoY Change -150.64% -49.66%
Cash From Investing Activities $50.60M -$125.6M
YoY Change -140.29% -47.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $14.17M $13.26M
YoY Change 6.82% -95.85%
NET CHANGE
Cash From Operating Activities $38.70M $21.26M
Cash From Investing Activities $50.60M -$125.6M
Cash From Financing Activities $14.17M $13.26M
Net Change In Cash $102.3M -$91.37M
YoY Change -212.01% -208.65%
FREE CASH FLOW
Cash From Operating Activities $38.70M $21.26M
Capital Expenditures $7.930M $7.710M
Free Cash Flow $30.77M $13.55M
YoY Change 127.03% -2783.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 dei Document Type
DocumentType
10-Q
CY2020Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q2 dei Entity File Number
EntityFileNumber
001-38044
CY2020Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q2 dei Document Period End Date
DocumentPeriodEndDate
2020-04-30
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2020Q2 dei Amendment Flag
AmendmentFlag
false
CY2020Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2020Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001660134
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1166000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4318000 USD
CY2019Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2019Q2 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2020Q1 us-gaap Goodwill
Goodwill
48000000 USD
CY2019Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 USD
CY2020 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q2 dei Entity Registrant Name
EntityRegistrantName
Okta, Inc.
CY2020Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
100 First Street, Suite 600
CY2020Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-4175727
CY2020Q2 dei City Area Code
CityAreaCode
888
CY2020Q2 dei Local Phone Number
LocalPhoneNumber
722-7871
CY2020Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2020Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94105
CY2020Q2 dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001 per share
CY2020Q2 dei Trading Symbol
TradingSymbol
OKTA
CY2020Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
619221000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
520048000 USD
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
827556000 USD
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
882976000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
111039000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
130115000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
34795000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
33636000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
40912000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32950000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
1633523000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
1599725000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61914000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53535000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
162763000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
125204000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
79270000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
77874000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
31032000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
32529000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
48023000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
48023000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20482000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18505000 USD
CY2020Q2 us-gaap Assets
Assets
2037007000 USD
CY2020Q1 us-gaap Assets
Assets
1955395000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8021000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3837000 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36601000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36887000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
31447000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
40300000 USD
CY2020Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
102198000 USD
CY2020Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
100703000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
392121000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
365236000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
1623911000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
570388000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
546963000 USD
CY2020Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
845862000 USD
CY2020Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
837002000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
194889000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
154511000 USD
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
6070000 USD
CY2020Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
6214000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6702000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
1550051000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5361000 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1168127000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1105564000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3742000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
892000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-758786000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-701124000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
413096000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
405344000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2037007000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1955395000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
182859000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
125223000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
48486000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35095000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
134373000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
90128000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48494000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34032000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
104043000 USD
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
82112000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34035000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25766000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
186572000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
141910000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-52199000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-51782000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
10764000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
4241000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4899000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2900000 USD
CY2020Q2 okta Interest Expenseand Other Nonoperating Income Expense
InterestExpenseandOtherNonoperatingIncomeExpense
5865000 USD
CY2019Q2 okta Interest Expenseand Other Nonoperating Income Expense
InterestExpenseandOtherNonoperatingIncomeExpense
1341000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58064000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53123000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-402000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1157000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-57662000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-51966000 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
123494000 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
112682000 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-57662000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-51966000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4634000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
195000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1784000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-333000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2850000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-138000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-54812000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-52104000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
413096000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
239444000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-57662000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-51966000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
37728000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
22685000 USD
CY2020Q2 okta Depreciation Amortizationand Accretion Excluding Amortizationof Deferred Sales Commissions
DepreciationAmortizationandAccretionExcludingAmortizationofDeferredSalesCommissions
5466000 USD
CY2019Q2 okta Depreciation Amortizationand Accretion Excluding Amortizationof Deferred Sales Commissions
DepreciationAmortizationandAccretionExcludingAmortizationofDeferredSalesCommissions
3399000 USD
CY2020Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10357000 USD
CY2019Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4025000 USD
CY2020Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
8680000 USD
CY2019Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
6328000 USD
CY2020Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-905000 USD
CY2019Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1369000 USD
CY2020Q2 us-gaap Noncash Contribution Expense
NoncashContributionExpense
536000 USD
CY2019Q2 us-gaap Noncash Contribution Expense
NoncashContributionExpense
0 USD
CY2020Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-915000 USD
CY2019Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
100000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18250000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9297000 USD
CY2020Q2 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-11865000 USD
CY2019Q2 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-9795000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3493000 USD
CY2019Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5975000 USD
CY2020Q2 okta Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-4055000 USD
CY2019Q2 okta Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-3066000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3943000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1640000 USD
CY2020Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2995000 USD
CY2019Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4143000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2773000 USD
CY2019Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3288000 USD
CY2020Q2 okta Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4270000 USD
CY2019Q2 okta Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-39000 USD
CY2020Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
26740000 USD
CY2019Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
20685000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38697000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21262000 USD
CY2020Q2 us-gaap Payments For Software
PaymentsForSoftware
1000000 USD
CY2019Q2 us-gaap Payments For Software
PaymentsForSoftware
369000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7930000 USD
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7710000 USD
CY2020Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
129079000 USD
CY2019Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
146545000 USD
CY2020Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
102293000 USD
CY2019Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
61244000 USD
CY2020Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
86320000 USD
CY2019Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
11996000 USD
CY2020Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2019Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
44223000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
50604000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-125607000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14172000 USD
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13388000 USD
CY2020Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5000 USD
CY2019Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-126000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14167000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13262000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1128000 USD
CY2019Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-282000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
102340000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-91365000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
531953000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
311215000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
634293000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219850000 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
784000 USD
CY2019Q2 us-gaap Interest Paid Net
InterestPaidNet
431000 USD
CY2020Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
209000 USD
CY2019Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
143000 USD
CY2020Q2 okta Stock Issued Early Vesting Of Exercised Options
StockIssuedEarlyVestingOfExercisedOptions
0 USD
CY2019Q2 okta Stock Issued Early Vesting Of Exercised Options
StockIssuedEarlyVestingOfExercisedOptions
128000 USD
CY2020Q2 okta Stock Issued During Period Value New Issues Charitable Contribution
StockIssuedDuringPeriodValueNewIssuesCharitableContribution
536000 USD
CY2019Q2 okta Stock Issued During Period Value New Issues Charitable Contribution
StockIssuedDuringPeriodValueNewIssuesCharitableContribution
0 USD
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
41444000 USD
CY2019Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1665000 USD
CY2020Q2 okta Property And Equipment Acquired Through Tenant Improvement Allowances
PropertyAndEquipmentAcquiredThroughTenantImprovementAllowances
2598000 USD
CY2019Q2 okta Property And Equipment Acquired Through Tenant Improvement Allowances
PropertyAndEquipmentAcquiredThroughTenantImprovementAllowances
0 USD
CY2020Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
533000 USD
CY2019Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
924000 USD
CY2020Q2 okta Stock Issued Executive Bonus Settlement
StockIssuedExecutiveBonusSettlement
9818000 USD
CY2019Q2 okta Stock Issued Executive Bonus Settlement
StockIssuedExecutiveBonusSettlement
2809000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
619221000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
208106000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2254000 USD
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
307000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12818000 USD
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
11437000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
634293000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219850000 USD
CY2020Q2 us-gaap Fiscal Period
FiscalPeriod
<span style="font-family:Arial;font-size:10pt;">The Company’s fiscal year ends on January 31. References to fiscal </span><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">2021</span><span style="font-family:Arial;font-size:10pt;">, for example, refer to the fiscal year ending </span><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">January 31, 2021</span>.
CY2020Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances. Actual results could vary from those estimates. The Company’s most significant estimates include the stand alone selling price (SSP) for each distinct performance obligation included in customer contracts with multiple performance obligations, the determination of the period of benefit for deferred commissions, the determination of the effective interest rate of the liability components of its convertible senior notes, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of deferred income tax assets, and the valuation of acquired intangible assets. </span></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In March 2020, </span><span style="font-family:Arial;font-size:10pt;">the World Health Organization (WHO) declared the outbreak of the novel coronavirus (COVID-19) a pandemic, which continues to spread across the globe. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the condensed consolidated financial statements for the period ended April 30, 2020. As events continue to evolve and additional information becomes available, our assumptions and estimates may change materially in future periods.</span></div>
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1205000 USD
CY2020Q2 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
1200000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1324939000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5969000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
138000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1330770000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1318359000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1319556000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
12 investment
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
7 investment
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 USD
CY2020Q2 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2020Q2 us-gaap Share Price
SharePrice
151.30
CY2020Q2 okta Capitalized Contract Costs Additions
CapitalizedContractCostsAdditions
11900000 USD
CY2019Q2 okta Capitalized Contract Costs Additions
CapitalizedContractCostsAdditions
9800000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
8700000 USD
CY2019Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
6300000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2020Q2 us-gaap Goodwill
Goodwill
48000000.0 USD
CY2020Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
56005000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24973000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
31032000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
54802000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22154000 USD
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
119000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32529000 USD
CY2020Q2 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
1300000 USD
CY2019Q2 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
500000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2800000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000 USD
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
147000000.0 USD
CY2019Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
98000000.0 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1240200000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
619100000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.50
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
7370000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
5463000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y8M12D
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y10M24D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.056
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.057
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
20796000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
35980000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
36482000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
37346000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
35305000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
99540000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
265449000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
52428000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
213021000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
7100000 USD
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2400000 USD
CY2020Q2 okta Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount
LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount
4700000 USD
CY2020Q2 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P4Y
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37728000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22685000 USD
CY2020Q2 okta Sharebased Compensation Arrangementby Sharebased Payment Award Number Of Equity Incentive Plans
SharebasedCompensationArrangementbySharebasedPaymentAwardNumberOfEquityIncentivePlans
2 incentive_plan
CY2020Q2 okta Common Stock Capital Shares Reserved For Future Issuance And Share Based Compensation Arrangement By Share Based Payment Award Outstanding Number
CommonStockCapitalSharesReservedForFutureIssuanceAndShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber
42754298 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12359302 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.82
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M12D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1436487000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
372829 shares
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
142.47
CY2020Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1449052 shares
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.78
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
116086 shares
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
21.22
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11166993 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.35
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1506963000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8283315 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.27
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y8M12D
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1176501000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
45600000 USD
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36073000 shares
CY2020Q2 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2020Q2 okta Unrecognizedstockbasedcompensationexpensesrelatedtounvested Rs Us
UnrecognizedstockbasedcompensationexpensesrelatedtounvestedRSUs
368200000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58100000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.007
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1200000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53100000 USD
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.022
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26909000 shares

Files In Submission

Name View Source Status
0001660134-20-000012-index-headers.html Edgar Link pending
0001660134-20-000012-index.html Edgar Link pending
0001660134-20-000012.txt Edgar Link pending
0001660134-20-000012-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
okta-20200430.xsd Edgar Link pending
okta-20200430_cal.xml Edgar Link unprocessable
okta-20200430_def.xml Edgar Link unprocessable
okta-20200430_lab.xml Edgar Link unprocessable
okta-20200430_pre.xml Edgar Link unprocessable
okta-430202010q.htm Edgar Link pending
okta-430202010q_htm.xml Edgar Link completed
okta-4302020ex311.htm Edgar Link pending
okta-4302020ex312.htm Edgar Link pending
okta-4302020ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending